MICHAEL JAMES BELSANTE MD NPI 1710118682

NPI Details

Michael James Belsante, MD is an urology in Mount Juliet, TN with 17 years of experience. The provider is a urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures. Michael James Belsante, MD NPI is 1710118682. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Graduation Year:2009

The provider's business location address is:

77 BELINDA PKWY STE 102
MOUNT JULIET, TN
ZIP 37122-635
Phone: (615) 391-4394
Fax: (615) 391-0284

The NPI 1710118682 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Automated urinalysis test (HCPCS:81003)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Ultrasound measurement of bladder capacity after voiding (HCPCS:51798)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Psa (prostate specific antigen) measurement, free (HCPCS:84154)
• Analysis for detection of tumor marker (HCPCS:86316)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Bacterial colony count, urine (HCPCS:87086)
• Insertion of implant in urethra within prostate gland using an endoscope, each additional implant (HCPCS:52442)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Bacterial urine culture (HCPCS:87088)
• Testosterone (hormone) level, total (HCPCS:84403)
• Detection test by nucleic acid for organism, quantification (HCPCS:87799)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) (HCPCS:87184)
• Electronic assessment of bladder emptying (HCPCS:51741)
• Complex measurement of pressure of urine flow in bladder with voiding pressure studies (HCPCS:51728)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Insertion of temporary bladder tube (HCPCS:51701)
• Initial hospital inpatient care per day, typically 30 minutes (HCPCS:99221)
• Insertion of sacral nerve neurostimulator electrode array (HCPCS:64561)
• Biopsy of prostate gland (HCPCS:55700)
• Insertion of stent in ureter using an endoscope (HCPCS:52332)
• Ultrasound scan of pelvic region through rectum (HCPCS:76872)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Red blood cell concentration measurement (HCPCS:85014)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Crushing of stone of ureter with insertion of stent using an endoscope (HCPCS:52356)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Infectious agent drug susceptibility analysis (HCPCS:87900)
• Detection test for candida species (yeast), quantification (HCPCS:87482)
• Detection test by nucleic acid for chlamydia trachomatis, quantification (HCPCS:87492)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), quantification (HCPCS:87592)
• Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique (HCPCS:87640)
• Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique (HCPCS:87641)
• Detection test by nucleic acid for strep (streptococcus, group a), quantification (HCPCS:87652)
• Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique (HCPCS:87653)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)
• Insertion of implant in urethra within prostate gland using an endoscope, 1 implant (HCPCS:52441)
• Diagnostic exam of bladder and urethra using an endoscope (HCPCS:52000)
• Surgical repair of vaginal defect using an endoscope (HCPCS:57425)
• Destruction of prostate tissue using radiofrequency induced heated water vapor (HCPCS:53854)
• Insertion of peripheral or gastric neurostimulator generator (HCPCS:64590)
• Prostate resection (HCPCS:NAN14)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/27/2009 and was last updated on 5/14/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: